Aurinia Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved its Lupkynis (voclosporin) treatment for use in adult patients with active lupus nephritis...
The ongoing COVID-19 pandemic has affected the routines of many practicing physicians, including an impact on their prescribing The post Assessing physician practices and expectations in...
The microbes in your gut influence how your immune system reacts to bacteria and viruses. A severe immune reaction is deadly; a small one lets the...
Phase 3 Trial Showed Eli Lilly’s bamlanivimab significantly reduced Covid-19 risk for nursing home residents
The 72-year-old patient was unable to mount her own immune defense against the SARS-CoV-2 virus because of chronic lymphocytic leukemia, which compromises normal immunity and immunoglobulin...
Credit: Cody Duty/UTHealth A pain management regimen comprised mostly of over-the-counter medication reduced opioid exposure in trauma patients while achieving equal levels of pain control, according...
Lifestyle medicine targets the root of chronic diseases like obesity, heart disease and diabetes. Experts explain why everyone should embrace these free prescriptions for good health.
Ella Balasa says she owes her life to the experimental phage therapy she was able access in no The post Education and empowerment would provide more...
Vivienne Raper, PhD, interviewed Michael Jacobson, PhD, managing partner at Cambridge Biostrategy Associates. Michael consults for companies that manufacture equipment, supplies, and services for the bioprocessing...
Genmab A/S announced on Jan. 15 that its drug, Darzalex Faspro has been approved by the US Food and Drug Administration (FDA) for the treatment of...
The COVID-19 pandemic shined a harsh spotlight on the challenges many elderly people face. Older adults are among the highest-risk groups for developing cases that need...
55 Americans Have Died Following COVID Vaccination, Norway Deaths Rise To 29 Amid increasing calls for suspension of the use of mRNA-based COVID-19 vaccines produced by...
Mesenchymal stem cells derived from umbilical cord tissue could help treat ARDS in Covid-19 patients, according to results of a Phase I/IIa clinical trial published by...
Low oxygen levels can be a sign that a patient is in danger. A device that measures oxygen levels has been shown to miss low oxygen...
AstraZeneca Plc's cancer drug Imfinzi was approved in Europe and Britain for a spaced-out regimen in a common type of lung cancer to help reduce the...
South Korea’s Celltrion has announced encouraging top-line results for its potential antibody therapy for COVID-19, with the first The post Celltrion closes in on COVID-19 antibody...
NextCure has found its new CMO after the previous executive resigned last August. Han Myint, a biopharma and academia veteran of more than 20 years, joined...
In the first episode of GEN Live for 2021, we’ll survey the state of biotech in 2021, relive some key moments in GEN’s first 40 years,...
In this second ‘Nine for 2021‘ article, IQVIA’s Sarah Rickwood looks at four issues which will directly impact The post Nine for 2021: Addressing the pandemic...
Last year, I published a paper that showed that cancer mortality rates fell by 24% between 2000 and 2016 and further that new cancer drugs accounted...
Sana Biotechnology is one of those startups that was sketched in on the chalkboard day one in the shape of a unicorn. A giant unicorn. And...
'Orphan drugs' with high price points are being tested as treatments for COVID-19. There's a better way to spur low-cost innovation for new drugs.
BioSpace looks at some of the top stories from Day 2 of the virtual JP Morgan Annual Healthcare Conference.
Credit: Cody Duty/UTHealth Researchers evaluating whether an investigational oral drug, vadadustat, can help prevent acute respiratory distress syndrome (ARDS) in COVID-19 patients were awarded $5.1 million...
Spike in evacuations for heart conditions Credit: Royal Flying Doctor Service New data released this week by Australian researchers reveals the impact of the COVID-19 lockdown...
Regeneron Pharmaceuticals has signed an agreement with the U.S. for the additional supply of 1.25 million doses of its antibody cocktail for the use in non-hospitalized...
The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical The post Coordinating and delivering research in the...
CNBC Exclusive: CNBC Transcript: Pfizer Chairman and CEO Albert Bourla speaks with CNBC’s “Squawk Box” today about the Covid vaccine manufacturing outlook. Q3 2020 hedge fund...
Despite some controversy over the effectiveness of Gilead Sciences’ Veklury (remdesivir), the product is bolstering the company’s bottom line.
With a new year comes the opportunity to think ahead for the market access landscape for the coming The post 2021 – UK market access prospects...